Magnacef

Generic Name: Cefixime

Magnacef (Cefixime) is a semi-synthetic third generation cephalosporin which has a bactericidal action against most strains of organisms including penicillinase producing strains.Magnacef has an average peak plasma concentrations occurring within 4 hrs after oral administration with a half-life of 3-4 hrs.

* Indications :
Magnacef is indicated for the treatment of:
- Upper respiratory tract infections: Otitis media, pharyngitis and tonsillitis.
- Lower respiratory tract infections: Acute bronchitis and acute exacerbation of chronic bronchitis.
- Uro-genital infections and sexually transmitted diseases such as gonorrhoea.

* Presentation• :
Magnacef – 200 Capsules: Each capsule contains Cefixime Trihydrate USP equivalent to 200 mg Cefixime. Blister packs of 8 capsules .
Magnacef – 400 Capsules: Each capsule contains Cefixime Trihydrate USP equivalent to 400 mg Cefixime.Blister packs of 6 ,5 capsules .
Magnacef for Oral Suspension: Each 5 ml of reconstituted suspension contains Cefixime Trihydrate USP equivalent to 100 mg Cefixime. Bottles of 30 & 60 ml suspension.
Hospital Packs of different sizes are available.
•All presentations may not be available in all countries.